Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma - Wikidata - wikimedia - TriplyDB

Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma

Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma

http://www.wikidata.org/entity/Q37187763

about

Heat shock proteins as danger signals for cancer detection Detection and identification of potential biomarkers of non-small cell lung cancer.Proteome serological determination of tumor-associated antigens in melanoma.Proteome-based analysis of serologically defined tumor-associated antigens in cutaneous lymphoma Autoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinoma Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma.Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.Serum autoantibody measurement for the detection of hepatocellular carcinoma Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer.Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line.Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma CIP2A overexpression induces autoimmune response and enhances JNK signaling pathway in human lung cancer.Effects of oxygen on the antigenic landscape of prostate cancer cells.An overview of biomarkers for the diagnosis of hepatocellular carcinoma.Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis.Serum autoantibodies as biomarkers for early cancer detection.Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC).Hsp60 chaperonopathies and chaperonotherapy: targets and agents.Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinoma Screening and identification of the tumor-associated antigen CK10, a novel potential liver cancer marker.Autoantibodies against heat shock proteins as biomarkers for the diagnosis and prognosis of cancer.An experimental protocol for the fractionation and 2DE separation of HeLa and A-253 cell lysates suitable for the identification of the individual antigenic proteome in Sjögren's syndrome.Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.A new type of protein chip to detect hepatocellular carcinoma-related autoimmune antibodies in the sera of hepatitis C virus-positive patients Using immunoproteomics to identify alpha-enolase as an autoantigen in liver fibrosis.Prognostic utility of autoantibodies to α-enolase and Hsp70 for cancer of the gingivo-buccal complex using immunoproteomics.A new versatile peptide-based size exclusion chromatography platform for global profiling and quantitation of candidate biomarkers in hepatocellular carcinoma specimens.Dr Eng M. Tan: a tribute to an enduring legacy in autoimmunity.A proteomic approach to study parathyroid glands

P2860

Q24273349-7767ADAD-D5B1-4619-99BA-54E2A4B14C98 Q30898054-C81CFBA7-B280-4CE4-AB34-034BA295AEE1 Q33432732-58519C46-F520-4D33-8EEA-2D640D684B3B Q33519571-F29D0E0D-BF4B-4EDC-9170-271C5C89BAD4 Q33648667-A208DB22-FD78-4AFC-B5A4-9BD72CBA8A1D Q33739952-BA6C7CDF-E52E-4A4A-A369-45D002DA1A25 Q33829604-8504C5B3-39A7-45B8-B538-1DBCCE142C34 Q33881201-7A2C1246-7659-4432-8E7D-7A5CBDCE5D05 Q34004797-F16BC139-A4E7-4C84-A302-97B812286DC2 Q34347517-A8147809-F322-4AC7-A5FD-D27AC9F4F49B Q34894246-C4858261-B0DF-4D5C-8B67-941EE1CBB758 Q35089751-DAAE7CA3-A29C-4C04-B673-9FAD522498A6 Q35170154-7848FDDA-5C00-4CBB-ADBD-63C6A8A18797 Q35343013-B473BEF6-A751-4AAF-BBFC-B534DBA5E4A9 Q35715964-C967D16A-2CD9-419B-8897-47A7C9E312B4 Q35839042-9906DD5E-F370-46BC-87C1-760692AF07ED Q35845496-A22FCBF3-182F-4C04-9999-EF8F5A82E4DD Q36395289-9C31B76C-B434-45D4-B321-68DEAEEA924A Q37213540-DA4BE302-C45C-405D-9FDC-8E32642A0D08 Q37622471-427805CA-26CB-4E7B-95B5-CC975282AB1D Q37856310-C4153E06-0B6F-493A-827B-A5073239477B Q38107971-A9D41A80-55D3-46F9-BE69-92723BBC32CE Q38167037-8B7315E3-357C-4734-BCD1-4FC11FE6FCE8 Q38452333-18407BF9-66A0-4EE5-B93F-1DFB13875E95 Q38704948-2672E4DE-E5A2-4C87-BC71-AA4C9C8487EB Q38781970-5477D39F-37FB-45D8-A0C9-8EA24591FBE2 Q39482700-194D0ED2-3B96-4A08-B47C-26D944A312F1 Q40522259-0B3F0933-E3AB-410E-AC95-7A6D9B7A7D18 Q41882623-7B2574CB-9DC8-46EC-9875-99B54EEA8758 Q42555303-9B779F10-96B3-4258-8B74-C69A04C49AB6 Q44159554-AE35CA09-87F1-4BFF-AE6D-BAA9B3988346 Q45277415-AE60FC09-8BAE-4C66-B634-50FD8BCEBB86 Q47187009-10F1623C-91AA-4B70-B2E4-5DB94D7941D3 Q59033585-62759104-D8BF-4320-A403-D185B1AE4748

P2860

Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma

http://www.wikidata.org/entity/Q37187763

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Using proteomic approach to id ...... rs in hepatocellular carcinoma

@en

Using proteomic approach to id ...... s in hepatocellular carcinoma.

@nl

type

label

Using proteomic approach to id ...... rs in hepatocellular carcinoma

@en

Using proteomic approach to id ...... s in hepatocellular carcinoma.

@nl

prefLabel

Using proteomic approach to id ...... rs in hepatocellular carcinoma

@en

Using proteomic approach to id ...... s in hepatocellular carcinoma.

@nl

P1433

Q37187763-C2431128-9D53-4276-9A50-FE5853E1F4A2

P1476

Q37187763-BA533269-91DD-4864-8FA2-C6CEAC6710EC

P2093

Q37187763-351E3C34-8DC3-4251-B01D-AC7185B71158

Q37187763-87EF1E28-201D-4E83-BF34-DC94643CE6DA

Q37187763-9C627CE0-CF6C-433F-A0D2-5F698D1A167A

Q37187763-A346D165-D0A3-44DF-94EC-D5BBA3D33137

Q37187763-DD1AD89A-A155-46B7-9F63-948053B33584

Q37187763-EAC1598A-B2F3-4E29-A623-629BC415EE14

P2860

Q37187763-069FCDCA-CDE5-4B17-A087-988AEDBBE949

Q37187763-14D26869-6A49-439F-B175-A8D9C09220B4

Q37187763-17F119C7-C4A6-4DA0-AD74-78A34828327A

Q37187763-236815E3-AA95-4D6C-9BBD-A80B54A75B19

Q37187763-254D9522-DF01-4E41-ACA0-A6DDA1BFFB3E

Q37187763-26554AB4-CDFE-46AB-BDE3-7F799CE111E1

Q37187763-2859F2C5-9D3F-4A3E-827A-4CE2C809CF9B

Q37187763-2D9C2B4A-86E7-427F-96D9-BA7F214BF57B

Q37187763-2E9EB27D-A0EB-476B-88C7-879A24FC99B9

Q37187763-421CA996-76C4-4CAC-BE59-1EF4F85838A1

P304

Q37187763-C10209A6-3679-45D8-B9FD-FA421C183DEE

P31

Q37187763-35923948-3760-4BBE-B9C2-5F9C845EB445

P356

Q37187763-4F6818B0-EFE9-44FB-8F72-B6ECC72C2B2D

P433

Q37187763-9125559F-A93D-4024-B731-D5E64F145C26

P478

Q37187763-4D6A59E0-D39E-479A-B207-81963F14A99A

P577

Q37187763-CA25732E-1349-4D26-98E5-557498552852

P5875

Q37187763-32562717-E542-4752-97BA-72102B588BFF

P698

Q37187763-8C8989FA-E857-45B1-ACC6-6D31D33748AA

P932

Q37187763-7AC2D2CF-0199-4E4E-B828-DA0DA5ECA552

P356

P1433

Journal of Proteome Research

P1476

Using proteomic approach to id ...... rs in hepatocellular carcinoma

@en

P2093

Eng M Tan

http://www.w3.org/2001/XMLSchema#string

Ernesto S Nakayasu

http://www.w3.org/2001/XMLSchema#string

Igor C Almeida

http://www.w3.org/2001/XMLSchema#string

Jian-Ying Zhang

http://www.w3.org/2001/XMLSchema#string

Kok Sun Looi

http://www.w3.org/2001/XMLSchema#string

Raquel A de Diaz

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle

Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress

A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma

The crystal structure of Ebp1 reveals a methionine aminopeptidase fold as binding platform for multiple interactions

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue

Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer

Overexpression of peroxiredoxin in human breast cancer

Expression of the 150-kd oxygen-regulated protein in human breast cancer

Toward the identification of liver toxicity markers: a proteome study in human cell culture and rats

P304

4004-4012

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/PR800273H

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23143073

http://www.w3.org/2001/XMLSchema#string

P698

18672925

http://www.w3.org/2001/XMLSchema#string

P932

2680441

http://www.w3.org/2001/XMLSchema#string